Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor
Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor
Rochester, New York, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer | Ear Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, carcinoma, epithelial neoplasm, head and neck cancer, hearing disorder, hearing loss disorder, neoplasm, nervous system disorder, otorhinolaryngologic disease, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT04915183 |